February 7, 2024 · Form 4 insider transaction
Atkinson Edward Morrow III bought 4,743 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Restricted stock unit award that vests in installments beginning on 02/17/2025.